
|Articles|June 20, 2023
Oligonucleotide Characterization by Agilent 1290 Infinity II Bio LC and 6545XT AdvanceBio LC/Q-TOF
Author(s)Agilent Technologies, Inc.
Characterization of oligonucleotides requires robust analytical instrumentation and methods as well as ease-of-use data analysis tools. Biocompatibility mitigates non-specific sample binding to flow path and it ensures the integrity of biomolecules and robustness of the system. In this study, two workflows, the Target Plus Impurities (TPI) and Sequence Confirmation workflows in Agilent MassHunter BioConfirm software, were carried out to characterize two oligonucleotide samples.
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
3
Hyphenated Chromatography Methods: Successes and Remaining Challenges
4
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
5
